跳至主要内容
临床试验/IRCT20180610040037N5
IRCT20180610040037N5招募中3 期

Examining the Effectiveness and Side Effects of Softgel-Encapsulated IMOD in Individuals Living with HIV

Tehran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Having written informed and voluntary consent.
  • The patient's age should be between 18 and 65 years.
  • The patient should have two positive HIV ELISA tests and one positive Western blot test.

排除标准

  • The patient has hepatitis B or C.
  • Pregnancy or breastfeeding.
  • Current use of illicit drugs or alcohol.
  • Use of growth hormone (within 30 days prior to study entry).
  • Use of testosterone or anabolic steroids (within 30 days prior to study entry).
  • Long-term treatment with immunosuppressive drugs (except for topical steroids).
  • Chemotherapy, interferon therapy, or radiotherapy (within three weeks prior to study entry).

研究者

相似试验